Dabur Pharma Ltd has recorded a profit before tax of Rs 17.73 crore for the first quarter ended June 30, an increase of 49.6 per cent over the profit before tax of Rs 11.82 crore in the corresponding period last year.
The gross sales of the company stood at Rs 80.67 crore for the quarter ended June 30, an increase of 11.7 per cent over gross sales of Rs 72.21 crore in the year-ago period, according to a company statement.
The company, however, did not disclose the net profit for the latest quarter in the statement. Repeated attempts to contact the company officials did not yield results.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app